HALO Precision Diagnostics Employee Directory
Hospitals and Health CareCalifornia, United States51-200 Employees
HALO Precision Diagnostics focuses on the early detection of leading causes of death by combining imaging, genomics, non-invasive liquid biomarkers, and large-scale community data with advanced analytics. The HALO Diagnostics platform coordinates these components to produce rapid, precise, and actionable results intended to guide physicians in selecting appropriate treatments. Based in Menlo Park, California, HALO Precision Diagnostics serves hospitals and other health care providers seeking earlier, more accurate diagnoses. In October 2023 the company announced a collaboration with Bayer AG to participate in QUANTI, Bayer's Phase III program for gadoquatrane. Within the hospital and health care sector, it positions itself as a provider of integrated precision diagnostic solutions for early disease detection.